Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer A Greenall

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cell Death Discovery|August 24, 2016
EGFRvIII: the promiscuous mutationSameer A Greenall, Terrance G Johns
Mabs|January 12, 2016
Incomplete target neutralization by the anti-cancer antibody rilotumumabSameer A Greenall, Timothy E Adams, Terrance G Johns
Translational Oncology|June 23, 2018
Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3Sameer A Greenall, Jacqueline Donoghue, Terrance G Johns, et al.
Avian Pathology : Journal of the W.V.P.A|October 19, 2010
Antibody fragments, expressed by a fowl adenovirus vector, are able to neutralize infectious bursal disease virusSameer A Greenall, Scott G Tyack, Michael A Johnson, et al.
Neoplasia (New York, N.Y.)|March 26, 2018
A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain TumorsRaelene Endersby, Jacqueline Whitehouse, Hilary Hii, et al.
Plos One|April 19, 2012
Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-METSameer A Greenall, Ermanno Gherardi, Zhanqi Liu, et al.
Cancers|November 12, 2013
Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent ActivationSusie I Ymer, Sameer A Greenall, Anna Cvrljevic, et al.
Obstetrics and Gynecology|October 3, 2013
Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growthUlrika W Nilsson, Terrance G Johns, Tania Wilmann, et al.
The Journal of Biological Chemistry|November 21, 2012
Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancerSameer A Greenall, John D Bentley, Lesley A Pearce, et al.
Cancers|July 26, 2018
Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic ResponseJacqueline F Donoghue, Lauren T Kerr, Naomi W Alexander, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cell Death Discovery|August 24, 2016
EGFRvIII: the promiscuous mutationSameer A Greenall, Terrance G Johns
Mabs|January 12, 2016
Incomplete target neutralization by the anti-cancer antibody rilotumumabSameer A Greenall, Timothy E Adams, Terrance G Johns
Translational Oncology|June 23, 2018
Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3Sameer A Greenall, Jacqueline Donoghue, Terrance G Johns, et al.
Avian Pathology : Journal of the W.V.P.A|October 19, 2010
Antibody fragments, expressed by a fowl adenovirus vector, are able to neutralize infectious bursal disease virusSameer A Greenall, Scott G Tyack, Michael A Johnson, et al.
Neoplasia (New York, N.Y.)|March 26, 2018
A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain TumorsRaelene Endersby, Jacqueline Whitehouse, Hilary Hii, et al.
Plos One|April 19, 2012
Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-METSameer A Greenall, Ermanno Gherardi, Zhanqi Liu, et al.
Cancers|November 12, 2013
Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent ActivationSusie I Ymer, Sameer A Greenall, Anna Cvrljevic, et al.
Obstetrics and Gynecology|October 3, 2013
Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growthUlrika W Nilsson, Terrance G Johns, Tania Wilmann, et al.
The Journal of Biological Chemistry|November 21, 2012
Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancerSameer A Greenall, John D Bentley, Lesley A Pearce, et al.
Cancers|July 26, 2018
Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic ResponseJacqueline F Donoghue, Lauren T Kerr, Naomi W Alexander, et al.
Pageof 2